Cargando…
Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N(2) non-small cell lung cancer
We conducted a phase I/II study to investigate whether the surgical resection after induction chemotherapy with cisplatin and irinotecan was feasible and could improve the treatment outcome for patients with pathological N(2) non-small cell lung cancer. Fifteen patients with stage IIIA non-small cel...
Autores principales: | Date, H, Kiura, K, Ueoka, H, Tabata, M, Aoe, M, Andou, A, Shibayama, T, Shimizu, N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375275/ https://www.ncbi.nlm.nih.gov/pubmed/11870532 http://dx.doi.org/10.1038/sj.bjc.6600117 |
Ejemplares similares
-
Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer
por: Katayama, H, et al.
Publicado: (2004) -
Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study
por: Ueoka, H, et al.
Publicado: (1999) -
Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group
por: Ueoka, H, et al.
Publicado: (2001) -
Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
por: Michel, P, et al.
Publicado: (2006) -
Evaluation of various cytological examinations by bronchoscopy in the diagnosis of peripheral lung cancer
por: Kawaraya, M, et al.
Publicado: (2003)